1. Home
  2. SPRC vs QCLS Comparison

SPRC vs QCLS Comparison

Compare SPRC & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • QCLS
  • Stock Information
  • Founded
  • SPRC 2004
  • QCLS 2014
  • Country
  • SPRC Israel
  • QCLS United States
  • Employees
  • SPRC N/A
  • QCLS N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • QCLS Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SPRC Health Care
  • QCLS Health Care
  • Exchange
  • SPRC Nasdaq
  • QCLS Nasdaq
  • Market Cap
  • SPRC 7.3M
  • QCLS 8.6M
  • IPO Year
  • SPRC N/A
  • QCLS N/A
  • Fundamental
  • Price
  • SPRC $4.27
  • QCLS $4.16
  • Analyst Decision
  • SPRC
  • QCLS
  • Analyst Count
  • SPRC 0
  • QCLS 0
  • Target Price
  • SPRC N/A
  • QCLS N/A
  • AVG Volume (30 Days)
  • SPRC 7.0M
  • QCLS 4.4M
  • Earning Date
  • SPRC 01-01-0001
  • QCLS 11-13-2025
  • Dividend Yield
  • SPRC N/A
  • QCLS N/A
  • EPS Growth
  • SPRC N/A
  • QCLS N/A
  • EPS
  • SPRC N/A
  • QCLS N/A
  • Revenue
  • SPRC $1,306,000.00
  • QCLS N/A
  • Revenue This Year
  • SPRC N/A
  • QCLS N/A
  • Revenue Next Year
  • SPRC N/A
  • QCLS N/A
  • P/E Ratio
  • SPRC N/A
  • QCLS N/A
  • Revenue Growth
  • SPRC N/A
  • QCLS N/A
  • 52 Week Low
  • SPRC $1.75
  • QCLS $3.24
  • 52 Week High
  • SPRC $37.59
  • QCLS $180.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.89
  • QCLS N/A
  • Support Level
  • SPRC $3.75
  • QCLS N/A
  • Resistance Level
  • SPRC $4.48
  • QCLS N/A
  • Average True Range (ATR)
  • SPRC 0.50
  • QCLS 0.00
  • MACD
  • SPRC -0.06
  • QCLS 0.00
  • Stochastic Oscillator
  • SPRC 38.85
  • QCLS 0.00

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About QCLS Q/C Technologies Inc. Common Stock

Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: